| Item Type | Name |
|
Academic Article
|
Surveillance options for patients with uveal melanoma following definitive management.
|
|
Concept
|
Melanoma
|
|
Concept
|
Melanoma, Experimental
|
|
Academic Article
|
A phase II study of gefitinib in patients with metastatic melanoma.
|
|
Academic Article
|
Profile of ipilimumab and its role in the treatment of metastatic melanoma.
|
|
Academic Article
|
Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma.
|
|
Academic Article
|
Delayed systemic recurrence of uveal melanoma.
|
|
Academic Article
|
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
|
|
Academic Article
|
BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
|
|
Academic Article
|
Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
|
|
Academic Article
|
Latest developments in the biology and management of uveal melanoma.
|
|
Academic Article
|
It's Right, Left is Rare.
|
|
Academic Article
|
The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor.
|
|
Academic Article
|
Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
|
|
Academic Article
|
Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma.
|
|
Academic Article
|
Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-a in patients with metastatic melanoma.
|
|
Academic Article
|
GNAQ mutation in a patient with metastatic mucosal melanoma.
|
|
Academic Article
|
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
|
|
Academic Article
|
Profile of selumetinib and its potential in the treatment of melanoma.
|
|
Academic Article
|
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
|
|
Academic Article
|
BRAF mutation testing with a rapid, fully integrated molecular diagnostics system.
|
|
Academic Article
|
Uveal melanoma
|
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
|
|
Academic Article
|
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
|
|
Academic Article
|
Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma
|
|
Academic Article
|
Profile of selumetinib and its potential in the treatment of melanoma
|
|
Academic Article
|
Adjunctive treatment strategies for high-risk ocular melanoma
|
|
Academic Article
|
A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
|
|
Academic Article
|
GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report.
|
|
Academic Article
|
Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
|
|
Academic Article
|
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
|
|
Academic Article
|
Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.
|
|
Academic Article
|
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
|
|
Academic Article
|
Uveal melanoma: From diagnosis to treatment and the science in between.
|
|
Academic Article
|
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.
|
|
Academic Article
|
A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
|
|
Academic Article
|
A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
|
|
Academic Article
|
Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
|
|
Academic Article
|
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
|
|
Academic Article
|
Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
|
|
Academic Article
|
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
|
|
Academic Article
|
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
|
|
Academic Article
|
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.
|
|
Academic Article
|
Obstacles to improving outcomes in the treatment of uveal melanoma.
|
|
Academic Article
|
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
|
|
Academic Article
|
Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall.
|
|
Academic Article
|
Immunotherapy for uveal melanoma.
|
|
Academic Article
|
Leptomeningeal disease in uveal melanoma: a case series.
|
|
Academic Article
|
Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study.
|
|
Academic Article
|
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
|
|
Academic Article
|
Adjuvant Ipilimumab in High-Risk Uveal Melanoma.
|
|
Academic Article
|
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
|
Academic Article
|
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
|
Academic Article
|
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
|
|
Academic Article
|
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
|
|
Concept
|
gp100 Melanoma Antigen
|
|
Academic Article
|
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
|
|
Academic Article
|
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
|
|
Academic Article
|
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
|
|
Academic Article
|
Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
|
|
Academic Article
|
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma.
|
|
Academic Article
|
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019).
|
|
Academic Article
|
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.
|
|
Academic Article
|
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
|
|
Academic Article
|
Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
|
|
Academic Article
|
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.
|
|
Academic Article
|
The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
|
|
Academic Article
|
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
|
|
Academic Article
|
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.
|
|
Academic Article
|
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
|
|
Academic Article
|
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
|
|
Academic Article
|
Adjuvant Pembrolizumab versus IFNa2b or Ipilimumab in Resected High-Risk Melanoma.
|
|
Academic Article
|
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
|
|
Academic Article
|
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
|
|
Academic Article
|
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
|
|
Academic Article
|
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions.
|
|
Academic Article
|
Case Report: Neuromyelitis Optica After Treatment of Uveal Melanoma With Nivolumab and Ipilimumab.
|
|
Academic Article
|
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.
|
|
Academic Article
|
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
|
Academic Article
|
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
|
|
Academic Article
|
Novel treatment paradigms for metastatic uveal melanoma.
|
|
Academic Article
|
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth.
|
|
Academic Article
|
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
|
|
Academic Article
|
New evidence for neoadjuvant therapy in advanced melanoma.
|
|
Academic Article
|
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
|
|
Academic Article
|
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
|
|
Academic Article
|
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
|
|
Academic Article
|
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
|
|
Academic Article
|
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA).
|
|
Academic Article
|
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
|